Vanda Pharmaceuticals (VNDA) Tops Q4 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
Vanda Pharmaceuticals (VNDA) PT Raised to $27 at Oppenheimer, 'Near-term Stock Set-up Remains Solid'
February 15, 2018 6:48 AM ESTOppenheimer raised its price target on Vanda Pharmaceuticals (NASDAQ: VNDA) to $27.00 (from $25.00) while maintaining a Outperform rating.
... More